Literature DB >> 26684547

Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes.

Maristela Pinheiro Freire1, Ligia Câmera Pierrotti2, Isabel Cristina Villela Soares Oshiro1, Patrícia Rodrigues Bonazzi3, Larissa Marques de Oliveira4, Anna Silva Machado1, Inneke Marie Van Der Heijden4, Flavia Rossi5, Silvia Figueiredo Costa4,2, Luiz Augusto Carneiro D'Albuquerque3, Edson Abdala2,3.   

Abstract

Infection with carbapenem-resistant Acinetobacter baumannii (CRAB) after liver transplantation (LT) is associated with high mortality. This study aimed to identify risk factors for post-LT CRAB infection, as well as to evaluate the impact of pre-LT CRAB acquisition on the incidence of post-LT CRAB infection. This was a prospective cohort study of all patients undergoing LT at our facility between October 2009 and October 2011. Surveillance cultures (SCs) were collected immediately before LT and weekly thereafter, until discharge. We analyzed 196 patients who were submitted to 222 LTs. CRAB was identified in 105 (53.6%); 24 (22.9%) of these patients were found to have acquired CRAB before LT, and 85 (81.0%) tested positive on SCs. Post-LT CRAB infection occurred in 56 (28.6%), the most common site being the surgical wound. Multivariate analysis showed that the risk factors for developing CRAB infection were prolonged cold ischemia, post-LT dialysis, LT due to fulminant hepatitis, and pre-LT CRAB acquisition with pre-LT CRAB acquisition showing a considerable trend toward significance (P = 0.06). Among the recipients with CRAB infection, 60-day mortality was 46.4%, significantly higher than among those without (P < 0.001). Mortality risk factors were post-LT infection with multidrug-resistant bacteria, LT performed because of fulminant hepatitis, retransplantation, prolonged cold ischemia, longer LT surgical time, and pre-LT CRAB acquisition, the last showing a trend toward significance (P = 0.08). In conclusion, pre-LT CRAB acquisition appears to increase the risk of post-LT CRAB infection, which has a negative impact on recipient survival. Liver Transplantation 22 615-626 2016 AASLD.
© 2015 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26684547     DOI: 10.1002/lt.24389

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

1.  Carbapenem-Resistant Enterobacteriaceae Acquired Before Liver Transplantation: Impact on Recipient Outcomes.

Authors:  Maristela Pinheiro Freire; Isabel C V S Oshiro; Ligia C Pierrotti; Patricia R Bonazzi; Larissa M de Oliveira; Alice T W Song; Carlos H Camargo; Inneke M van der Heijden; Flavia Rossi; Silvia F Costa; Luiz A C DʼAlbuquerque; Edson Abdala
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

2.  Predictors of postoperative infectious complications in liver transplant recipients: experience of 185 consecutive cases.

Authors:  Seungjin Lim; Eun Jung Kim; Tae Beom Lee; Byung Hyun Choi; Young Mok Park; Kwangho Yang; Je Ho Ryu; Chong Woo Chu; Su Jin Lee
Journal:  Korean J Intern Med       Date:  2018-02-23       Impact factor: 2.884

3.  Bacterial and Fungal Infections After Liver Transplantation: Microbial Epidemiology, Risk Factors for Infection and Death with Infection.

Authors:  Weili Zhang; Wentao Wang; Mei Kang; Siying Wu; Ya Liu; Quanfeng Liao; Yuling Xiao; Ying Ma; Yi Xie
Journal:  Ann Transplant       Date:  2020-05-19       Impact factor: 1.530

Review 4.  Prevalence, Risk Factors And Treatment Of The Most Common Gram-Negative Bacterial Infections In Liver Transplant Recipients: A Review.

Authors:  Mojtaba Shafiekhani; Mahtabalsadat Mirjalili; Afsaneh Vazin
Journal:  Infect Drug Resist       Date:  2019-11-13       Impact factor: 4.003

5.  Drug Resistance and Risk Factors for Acquisition of Gram-Negative Bacteria and Carbapenem-Resistant Organisms Among Liver Transplant Recipients.

Authors:  Xiaoxia Wu; Guo Long; Weiting Peng; Qiquan Wan
Journal:  Infect Dis Ther       Date:  2022-05-13

6.  Epidemiology, Risk Factors and Outcome Due to Multidrug Resistant Organisms in Paediatric Liver Transplant Patients in the Era of Antimicrobial Stewardship and Screening.

Authors:  Anita Verma; Sunitha Vimalesvaran; Anil Dhawan
Journal:  Antibiotics (Basel)       Date:  2022-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.